Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Immunother. 2013 Sep;36(7):382–389. doi: 10.1097/CJI.0b013e31829fb7a2

Table 2.

Adverse Events

Arm 1 N=15 Arm 2 N=15 Total N=30
Immune Related Adverse Events Grade 1/2 Grade 3/4 Grade 1/2 Grade 3/4 Grade 1/2 Grade 3/4
Dermatological
Localized 0 0 15 0 15 0
Systemic* 9 0 11 1 20 1
Endocrine
Adrenal insufficiency 0 0 1 0 1 0
Hypophysitis 2 0 1 0 3 0
HEENT
Conjunctivitis 1 0 0 0 1 0
Gastrointestinal
Colitis 2 1 3 1 5 2
Neurological
Guillain-Barre Syndrome 0 1 0 0 0 1
Pulmonary
Pneumonitis 0 0 0 1 0 1
Renal
Nephritis 0 1 0 0 0 1
Other Related Adverse Events
Constitutional
Arthralgias 0 0 1 0 1 0
Anorexia 0 0 2 0 2 0
Cramps 1 0 0 0 1 0
Diarrhea 0 0 2 0 2 0
Dry eye 1 0 0 0 1 0
Dry skin 1 0 0 0 1 0
Fatigue 0 0 6 0 6 0
Fever 3 0 5 0 8 0
Flu-like symptoms 2 0 4 0 6 0
Headache 0 0 3 0 3 0
Nausea 1 0 2 0 3 0
*

While there was only one grade 3 rash observed in arm 2, rashes were more severe/symptomatic than in arm 1.